Related Experiment Video
Updated: Oct 19, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas
Y Kitagawa1, K Kunimi, T Uchibayashi
1Department of Urology, Kanazawa University School of Medicine, Cancer Research Institute, Ishikawa, Japan.
Purpose:
Three different membrane-type matrix metalloproteinases (MT1, 2, and 3-MMP) that can activate proMMP-2 (progelatinase A) are thought to play an important role in invasion and metastasis by various human carcinomas. To further clarify this role, we examined mRNA expression of MT-MMPs in human renal cell carcinomas.
Materials And Methods:
mRNA was extracted from 25 clinical specimens of renal cell carcinoma and 23 specimens of normal renal parenchyma remote from the tumor. Reverse transcription polymerase chain reaction (RT-PCR) using specific primers was performed, and PCR products were hybridized to 32P-labeled internal probes and analyzed by a bioimage analyzer.
Results:
MT1, 2, and 3-MMP mRNA expression in carcinomas was significantly higher than in normal parenchyma. In terms of the pathologic stage, MT1-MMP mRNA expression in pT2 and pT3 tumors was significantly higher than those in pT1 tumors. Although the sample size was small, it was evident that MT3-MMP mRNA expression in clear cell subtype renal cell carcinomas was higher than in the group of tumors including the granular cell subtype.
Conclusions:
These three MT-MMPs may play an important role in the pathogenesis of human renal cell carcinoma, and MT1-MMP in particular is important in invasion by carcinoma cells. It is interesting that the expression of MT3-MMP was higher in carcinomas, especially clear cell carcinoma, than in normal parenchyma, so that MT3-MMP may provide a clue an understanding of the molecular mechanism of carcinogenesis in human kidney.
Insights
Three membrane-type matrix metalloproteinases (MT-MMPs) show increased mRNA expression in renal cell carcinomas compared to normal tissue. MT1-MMP is linked to advanced tumor stages, and MT3-MMP is elevated in clear cell subtypes, suggesting roles in kidney cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Membrane-type matrix metalloproteinases (MT-MMPs) activate proMMP-2, a key enzyme in extracellular matrix degradation.
- MT-MMPs are implicated in the invasion and metastasis of various human carcinomas.
- Understanding MT-MMP roles in renal cell carcinoma (RCC) is crucial for targeted therapies.
Purpose of the Study:
- To investigate the mRNA expression levels of three MT-MMPs (MT1, MT2, and MT3-MMP) in human renal cell carcinomas.
- To correlate MT-MMP expression with clinicopathological features of RCC.
Main Methods:
- mRNA was extracted from 25 RCC specimens and 23 normal renal parenchyma samples.
- Reverse transcription polymerase chain reaction (RT-PCR) was employed to detect MT-MMP mRNA.
- PCR products were analyzed using hybridization with 32P-labeled probes and a bioimage analyzer.
Main Results:
- MT1, MT2, and MT3-MMP mRNA expression was significantly higher in RCC tissues than in normal tissues.
- MT1-MMP mRNA expression correlated positively with advanced pathological stages (pT2 and pT3).
- MT3-MMP mRNA expression was notably higher in clear cell subtype RCC compared to other subtypes.
Conclusions:
- The three MT-MMPs likely contribute to the pathogenesis of human renal cell carcinoma.
- MT1-MMP appears particularly important in the invasive behavior of carcinoma cells.
- Elevated MT3-MMP expression in RCC, especially clear cell type, may offer insights into kidney cancer's molecular mechanisms.
Related Concept Videos
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Matrix Metalloproteases in Degradation of ECM
A...